Unconfigured Ad

Collapse
X
 
  • Time
  • Show
Clear All
new posts
  • mbblack
    Senior Member
    • Aug 2009
    • 245

    #1

    CuffLinks/CuffDiff frag length for single-end reads

    I have 6 samples, single-end RNAseq runs from a SOLiD 4 machine, and mapped using BioScope 1.3. These are a set of 3 treatment animals and 3 controls (mice). These were barcoded samples (2 slides), 50bp reads.

    My aim is to use CuffDiff (1.2.1) to look at differential expression (and I want to compare to DESeq, and maybe other tools as well). But I am wondering what exactly I should enter for the mean fragment length and standard deviation. I've read the posts mentioning this should be the reads plus the adapters, but that makes no sense to me given the BAM files I have from BioScope. The length of the reads plus adapters, barcode and so forth is 127bp, which means nothing relative to what is actually in my input BAM files for this analysis.

    Taking those BAM files (the wt.sr.bam files from BioScope) I used FastQC to get the fragment length distribution for each wt.sr.bam file produced from the BioScope 1.3 mapping runs, dumped the data from FastQC into JMP Genomics and pulled up the distribution stats.

    Sample Mean Length Std. Dev.
    Treatment -1: 46.71 6.31 (~71.9 million map'd reads)
    Treatment -2: 46.59 6.42 (~72.4 million map'd reads)
    Treatment -3: 45.96 7.26 (~77.5 million map'd reads)
    Control -1: 45.41 7.34 (~76.0 million map'd reads)
    Control -2: 45.66 7.36 (~171.6 million map'd reads)
    Control -3: 46.26 6.69 (~109.4 million map'd reads)
    Combined samples: 46.027 6.997

    Now, it seems to me I should be using the values for the combined samples in CuffDiff, as that is derived directly from the reads which CuffDiff will be chewing on? I was thinking I'd set "-m 46 -s 7" in the CuffDiff command.

    Does that seem logical?

    If not, just how does one come up with the fragment length and standard deviation for single end reads?

    Thanks, Michael
    Last edited by mbblack; 12-13-2011, 04:56 PM.
    Michael Black, Ph.D.
    ScitoVation LLC. RTP, N.C.
  • polsum
    Member
    • May 2009
    • 32

    #2
    I have the same question. I will wait for the experts to answer.

    Comment

    • polyatail
      Member
      • Dec 2010
      • 25

      #3
      The fragment length is the size of the piece of DNA that was sequenced, which is generally significantly longer than the length of the reads. In a paired end run, you can estimate the fragment length by observing the distance in genome coordinates between mapped reads. In a single end run, the only way you'll know is based on the size range that was selected on a gel during library prep. If, for example, the 300-400 bp band was cut out and adapters are 90 bp, your fragment length is 210-310 bp. The SD can vary depending on how wide the size selection was.

      In this case I would ask whoever prepared the library what the fragment length was. I'm not familiar with the requirements of SOLiD, but there may be a fragment size limit and a size that is usually selected, like Illumina.
      Last edited by polyatail; 12-17-2011, 02:54 PM.

      Comment

      Latest Articles

      Collapse

      • SEQadmin2
        Beyond CRISPR/Cas9: Understand, Choose, and Use the Right Genome Editing Tool
        by SEQadmin2



        CRISPR/Cas9 sparked the gene editing revolution for both research and therapeutics.1 But this system still showed severe issues that limited its applications. The most prominent were the heavy reliance on PAM sequences, delivery limitations, double-stranded breaks that prompt unintended edits and cell death, and editing inefficiency (both in targeting and in knock-in reliability).

        Despite this, “CRISPR helped turn genome editing from a specialized technique into
        ...
        07-31-2026, 11:01 AM
      • SEQadmin2
        Proteomic Platforms: How to Choose the Right Analytical Strategy to Improve Detection and Clinical Applications
        by SEQadmin2


        Proteomics platforms are evolving rapidly, with advances in mass spectrometry and affinity-based approaches expanding what researchers can detect and at what scale. As the field moves toward deeper proteome coverage and clinical applications, scientists face an increasingly complex landscape of tools. This article will explore how researchers are navigating these choices to find the right platform for their work.

        The systematic characterization of the human proteome has
        ...
        07-20-2026, 11:48 AM
      • SEQadmin2
        Advanced Sequencing Platforms Tackle Neuroscience’s Toughest Genomics Problems
        by SEQadmin2



        Genomics studies in neuroscience face a special challenge due to the brain’s complexity and scarcity of samples. Mapping changes in cell type and state using conventional next-generation sequencing methods remains challenging. Advances in technologies like single-cell sequencing, spatial transcriptomics, and long-read sequencing have opened the door to deeper studies of the brain and diseases like Alzheimer’s, amyotrophic lateral sclerosis (ALS), and schizophrenia.
        ...
        07-09-2026, 11:10 AM

      ad_right_rmr

      Collapse

      News

      Collapse

      Topics Statistics Last Post
      Started by SEQadmin2, Yesterday, 10:13 AM
      0 responses
      14 views
      0 reactions
      Last Post SEQadmin2  
      Started by SEQadmin2, 07-31-2026, 02:55 AM
      0 responses
      27 views
      0 reactions
      Last Post SEQadmin2  
      Started by SEQadmin2, 07-24-2026, 12:17 PM
      0 responses
      20 views
      0 reactions
      Last Post SEQadmin2  
      Started by SEQadmin2, 07-23-2026, 11:41 AM
      0 responses
      19 views
      0 reactions
      Last Post SEQadmin2  
      Working...